Big Pharma must not profiteer from monopoly

WITH reference to Azrul Mohd Khalib’s letter on “Politics of rare diseases”, (The Star, Aug 29), as a former lecturer, I know that medical students are fascinated by rare diseases even though they may not encounter these diseases again as doctors.

Both under-graduate and post-graduate examinations tend to use rare presentations of common diseases or common presentations of rare diseases for their clinical cases. But as practising clinicians, the reality would set in.